According to the company, the data at 21 months of median follow up confirms a statistically- significant six-month increase in median survival (17.1 months in the experimental arm
The HepaMate technology has previously been tested in clinical Phase I and pivotal Phase II/III studies involving more than 200 patients. According to the company, a retrospective statistical
Most recently, Mr Falvey served as CFO for Aspect Medical Systems, a provider of brain monitoring technologies. Prior to Aspect, Mr Falvey was vice president of finance at
According to the company, Smart Dilator is the first esophageal dilator to indicate the pressure level being applied at the esophageal stricture. Jeffrey Spragens, president and CEO of
With this election, Mr Represas will become one of 13 outside directors on the 14-member board. Mr Represas will stand for election by the company’s stockholders in April
The devices are approved for the treatment of occlusive disease in native superficial femoral arteries and proximal popliteal arteries, and are marketed by the Bard peripheral vascular division,
Mr Slansky has served for the past six years as the president and CFO of Poway, California-based SpaceDev, a publicly traded space technology/aerospace company. Mr Slansky has received
The new contract is effective for one year with an auto-renewal provision. Gregory Weishar, CEO of PharMerica, said: “Golden Living is a valued client and we are pleased
Denmark-based biopharmaceutical company NeuroSearch has signed an agreement with Eli Lilly to form a three-year drug discovery and development alliance to investigate a defined number of undisclosed ion
Teva Pharmaceutical Industries, a generic pharmaceutical company, has posted a net loss of $688 million, or $0.88 per diluted share, in the fourth quarter of 2008, compared to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.